AR122325A2 - Antígeno ndv recombinante y usos del mismo - Google Patents
Antígeno ndv recombinante y usos del mismoInfo
- Publication number
- AR122325A2 AR122325A2 ARP200102888A ARP200102888A AR122325A2 AR 122325 A2 AR122325 A2 AR 122325A2 AR P200102888 A ARP200102888 A AR P200102888A AR P200102888 A ARP200102888 A AR P200102888A AR 122325 A2 AR122325 A2 AR 122325A2
- Authority
- AR
- Argentina
- Prior art keywords
- ndv
- polypeptide
- vaccines
- microalgae
- plants
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title abstract 4
- 108091007433 antigens Proteins 0.000 title abstract 4
- 102000036639 antigens Human genes 0.000 title abstract 4
- 241000711404 Avian avulavirus 1 Species 0.000 abstract 9
- 101710133291 Hemagglutinin-neuraminidase Proteins 0.000 abstract 5
- 229920001184 polypeptide Polymers 0.000 abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 5
- 244000207740 Lemna minor Species 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- 229940031626 subunit vaccine Drugs 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 241000195493 Cryptophyta Species 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 108010076504 Protein Sorting Signals Proteins 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
- 239000003981 vehicle Substances 0.000 abstract 1
- 229940023147 viral vector vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
- C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/17—Newcastle disease virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/517—Plant cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Pulmonology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Plant Pathology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Vacunas contra el NDV que comprenden vacunas de subunidades basadas en HN del NDV. El HN NDV se puede expresar en plantas o algas, inclusive microalgas. La invención también abarca vectores recombinantes que codifican y expresan antígenos, epitopes o inmunógenos del NDV que se pueden usar para proteger animales contra el NDV. También abarca un régimen de vacunación compatible con la estrategia DIVA, incluyendo un esquema desensibilización-refuerzo usando vacunas y vacunas de subunidades inactivadas o de vectores virales. Reivindicación 1: Una composición, caracterizada porque comprende un polipéptido o antígeno HN (hemaglutinina-neuraminidasa) del NDV (virus de la enfermedad de Newcastle) y un transportador, excipiente, vehículo o adyuvante farmacéuticamente aceptable o apto para uso veterinario. Reivindicación 16: Un polipéptido o antígeno del NDV sustancialmente purificado expresado en microalgas o plantas de lenteja de agua, caracterizado porque dicho polipéptido comprende una secuencia de aminoácidos que tiene al menos un 80% de identidad de secuencia con un polipéptido que tiene la secuencia que se muestra en la SEQ ID Nº 3, 5, 7, 9, 15, 17, 19 ó 20. Reivindicación 17: Un cultivo de microalgas o plantas de lenteja de agua, caracterizado porque fue transformado de manera estable con un gen que expresa un polipéptido HN NDV o un fragmento o una variante del mismo. Reivindicación 21: Un plásmido, caracterizado porque comprende un fragmento de ADN que codifica un péptido señal que tiene la secuencia que se muestra en la SEQ ID Nº 13 ó 21.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29029709P | 2009-12-28 | 2009-12-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR122325A2 true AR122325A2 (es) | 2022-08-31 |
Family
ID=44189168
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP100104979A AR079767A1 (es) | 2009-12-28 | 2010-12-28 | Antigeno ndv (virus de la enfermedad de newcastle) recombinante y usos del mismo |
ARP200102888A AR122325A2 (es) | 2009-12-28 | 2020-10-19 | Antígeno ndv recombinante y usos del mismo |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP100104979A AR079767A1 (es) | 2009-12-28 | 2010-12-28 | Antigeno ndv (virus de la enfermedad de newcastle) recombinante y usos del mismo |
Country Status (11)
Country | Link |
---|---|
US (1) | US10633667B2 (es) |
EP (2) | EP2519258B1 (es) |
JP (1) | JP5933451B2 (es) |
KR (1) | KR20120101572A (es) |
CN (1) | CN103260643A (es) |
AR (2) | AR079767A1 (es) |
CA (1) | CA2785653C (es) |
DO (1) | DOP2012000187A (es) |
MX (1) | MX351643B (es) |
PE (1) | PE20121685A1 (es) |
WO (1) | WO2011090708A2 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9012197B2 (en) * | 2009-12-28 | 2015-04-21 | Merial, Inc. | Production of hemagglutinin-neuraminidase protein in microalgae |
CA3153553A1 (en) * | 2009-12-28 | 2011-07-28 | Sanofi Vaccine Technologies, S.A.S. | Methods of producing heterologous proteins comprising membrane domains in microalgal extracellular bodies |
MX351695B (es) * | 2011-05-07 | 2017-10-24 | Laboratorio Avi Mex S A De C V | Vacuna recombinante contra el síndrome reproductivo y respiratorio porcino en vector viral. |
WO2013063388A1 (en) * | 2011-10-28 | 2013-05-02 | The Regents Of The University Of California | Diatom-based vaccines |
EP2660324A1 (en) * | 2012-05-02 | 2013-11-06 | Algenics | Production of secreted therapeutic antibodies in microalgae |
EP2660323A1 (en) * | 2012-05-02 | 2013-11-06 | Algenics | Production of secreted therapeutic antibodies in phaeodactylum tricornutum microalgae |
US20150112045A1 (en) * | 2012-05-02 | 2015-04-23 | Algenics | Production of secreted therapeutic antibodies in microalgae |
EP2671950A1 (de) * | 2012-06-06 | 2013-12-11 | Philipps-Universität Marburg | Expression und Sekretion von rekombinanten, vollständig assemblierten Proteinkomplexen durch Mikroalgen |
CN104059927B (zh) * | 2014-05-09 | 2018-01-09 | 中国农业科学院生物技术研究所 | 鸡新城疫糖蛋白病毒抗原的制备方法及其产品 |
CN105567715B (zh) * | 2014-10-17 | 2021-06-29 | 丰益(上海)生物技术研发中心有限公司 | 裂殖壶菌α-微管蛋白相关序列及其应用 |
WO2016073739A1 (en) * | 2014-11-05 | 2016-05-12 | Research Institute At Nationwide Children's Hospital | Methods and materials for producing recombinant viruses in eukaryotic microalgae |
US10196616B2 (en) * | 2017-02-15 | 2019-02-05 | The United States Of America, As Represented By The Secretary Of Agriculture | Altered avian virus for in-ovo inoculation and methods of use thereof |
CN107099513B (zh) * | 2017-06-22 | 2020-07-14 | 北京邦卓生物科技有限公司 | 一种共表达ndv hn和ibdv vp2基因的hvt的构建及其应用 |
CN113652406B (zh) * | 2021-09-01 | 2023-05-02 | 青岛易邦生物工程有限公司 | 一种鸡传染性喉气管炎重组病毒株及其应用 |
Family Cites Families (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2909462A (en) | 1955-12-08 | 1959-10-20 | Bristol Myers Co | Acrylic acid polymer laxative compositions |
US5505941A (en) | 1981-12-24 | 1996-04-09 | Health Research, Inc. | Recombinant avipox virus and method to induce an immune response |
CA1247080A (en) | 1983-03-08 | 1988-12-20 | Commonwealth Serum Laboratories Commission | Antigenically active amino acid sequences |
US5380831A (en) | 1986-04-04 | 1995-01-10 | Mycogen Plant Science, Inc. | Synthetic insecticidal crystal protein gene |
US4761373A (en) | 1984-03-06 | 1988-08-02 | Molecular Genetics, Inc. | Herbicide resistance in plants |
EP0173552B1 (en) | 1984-08-24 | 1991-10-09 | The Upjohn Company | Recombinant dna compounds and the expression of polypeptides such as tpa |
US4945050A (en) | 1984-11-13 | 1990-07-31 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues and apparatus therefor |
KR950008571B1 (ko) | 1986-01-08 | 1995-08-03 | 롱쁠랑 아그로시미 | 할로아릴니트릴 분해 유전자, 그의 용도 및 이를 함유한 세포 |
GB8717430D0 (en) | 1987-07-23 | 1987-08-26 | Celltech Ltd | Recombinant dna product |
US5990387A (en) | 1988-06-10 | 1999-11-23 | Pioneer Hi-Bred International, Inc. | Stable transformation of plant cells |
NZ230375A (en) | 1988-09-09 | 1991-07-26 | Lubrizol Genetics Inc | Synthetic gene encoding b. thuringiensis insecticidal protein |
DE69033816T2 (de) | 1989-02-24 | 2002-08-08 | Monsanto Technology Llc | Synthetische pflanzengene und verfahren zu ihrer herstellung |
US5879918A (en) | 1989-05-12 | 1999-03-09 | Pioneer Hi-Bred International, Inc. | Pretreatment of microprojectiles prior to using in a particle gun |
US5202422A (en) | 1989-10-27 | 1993-04-13 | The Scripps Research Institute | Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins and method of their use |
EP0528819A1 (en) | 1990-04-18 | 1993-03-03 | Plant Genetic Systems, N.V. | Modified bacillus thuringiensis insecticidal-crystal protein genes and their expression in plant cells |
US5932782A (en) | 1990-11-14 | 1999-08-03 | Pioneer Hi-Bred International, Inc. | Plant transformation method using agrobacterium species adhered to microprojectiles |
US6309647B1 (en) | 1999-07-15 | 2001-10-30 | Aventis Pasteur | Poxvirus—canine dispemper virus (CDV) or measles virus recombinants and compositions and methods employing the recombinants |
DE69233158T2 (de) | 1991-03-07 | 2004-05-13 | Connaught Technology Corp., Greenville | Gentechnologisch hergestellter stamm für impfstoffe |
US5863542A (en) | 1991-03-07 | 1999-01-26 | Virogenetics Corporation | Recombinant attenuated ALVAC canaryopox virus containing heterologous HIV or SIV inserts |
TW261517B (es) | 1991-11-29 | 1995-11-01 | Mitsubishi Shozi Kk | |
EP0652965A1 (en) | 1992-07-27 | 1995-05-17 | Pioneer Hi-Bred International, Inc. | An improved method of agrobacterium-mediated transformation of cultured soybean cells |
JP3347736B2 (ja) | 1993-11-19 | 2002-11-20 | バイオテクノロジー・リサーチ・アンド・デイベロツプメント・コーポレイシヨン | 植物中で遺伝子を発現させるためのキメラ調節領域及び遺伝子カセット |
EP0826063A1 (en) | 1995-04-25 | 1998-03-04 | Vical Incorporated | Single-vial formulations of dna/lipid complexes |
US6020169A (en) | 1995-07-20 | 2000-02-01 | Washington State University Research Foundation | Production of secreted foreign polypeptides in plant cell culture |
US5846946A (en) | 1996-06-14 | 1998-12-08 | Pasteur Merieux Serums Et Vaccins | Compositions and methods for administering Borrelia DNA |
FR2750866B1 (fr) | 1996-06-27 | 1998-11-27 | Rhone Merieux | Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire |
FR2751229B1 (fr) | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins |
FR2751224B1 (fr) | 1996-07-19 | 1998-11-20 | Rhone Merieux | Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs |
FR2751228B1 (fr) | 1996-07-19 | 1998-11-20 | Rhone Merieux | Vaccin polynucleotidique bovin pour voie intradermique |
FR2751226B1 (fr) | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique contre les pathologies du cheval |
FR2751227B1 (fr) | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives |
FR2751225B1 (fr) | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique aviaire |
ES2241042T3 (es) | 1996-10-11 | 2005-10-16 | The Regents Of The University Of California | Conjugados de polinucleotido inmunoestimulador/ molecula inmunomoduladora. |
US5981840A (en) | 1997-01-24 | 1999-11-09 | Pioneer Hi-Bred International, Inc. | Methods for agrobacterium-mediated transformation |
FR2758986B1 (fr) | 1997-01-31 | 1999-04-30 | Rhone Merieux | Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire |
WO1999001158A1 (fr) | 1997-06-30 | 1999-01-14 | Rhone-Poulenc Rorer S.A. | Amelioration du transfert d'acide nucleique dans le muscle strie et combinaison permettant la mise en oeuvre du procede |
US6040498A (en) | 1998-08-11 | 2000-03-21 | North Caroline State University | Genetically engineered duckweed |
US7161064B2 (en) * | 1997-08-12 | 2007-01-09 | North Carolina State University | Method for producing stably transformed duckweed using microprojectile bombardment |
FR2778858B1 (fr) | 1998-05-20 | 2000-06-16 | Oreal | Emulsion e/h/e stable et son utilisation comme composition cosmetique et/ou dermatologique |
US8003772B2 (en) | 1999-01-14 | 2011-08-23 | Martek Biosciences Corporation | Chimeric PUFA polyketide synthase systems and uses thereof |
FR2801607B1 (fr) | 1999-11-26 | 2001-12-28 | Merial Sas | Pneumovirus du canard et vaccins correspondants |
US6852705B2 (en) | 2000-01-21 | 2005-02-08 | Merial | DNA vaccines for farm animals, in particular bovines and porcines |
PT1305437E (pt) | 2000-07-31 | 2010-11-12 | Biolex Therapeutics Inc | Expressão de polipéptidos biologicamente activos na lentilha de água |
ES2278810T3 (es) | 2000-11-02 | 2007-08-16 | Intervet International Bv | Nucleoproteina recombinante mutante del virus de la enfermedad de newcastle (ndv) como marcador de vacuna. |
TWI350854B (en) * | 2001-04-16 | 2011-10-21 | Martek Biosciences Corp | Product and process for transformation of thraustochytriales microorganisms |
US7709699B2 (en) | 2001-05-30 | 2010-05-04 | Biolex Therapeutics, Inc. | Use of duckweed in high throughput screening |
ES2320119T3 (es) * | 2002-08-27 | 2009-05-19 | Dow Agrosciences Llc | Uso de toxina remolabil de escherichia coli como adyvante en aves de corral. |
NZ542933A (en) * | 2003-05-05 | 2009-08-28 | Dow Agrosciences Llc | Stable immunoprophylactic and therapeutic compositions derived from transgenic plant cells and methods for production |
US7132291B2 (en) | 2003-05-05 | 2006-11-07 | Dow Agro Sciences Llc | Vectors and cells for preparing immunoprotective compositions derived from transgenic plants |
RU2354399C2 (ru) | 2003-07-24 | 2009-05-10 | Мериал Лимитед | Вакцинная композиция и способ индуцирования иммунологического ответа у животного |
EP1789530B1 (en) * | 2004-08-05 | 2015-10-07 | Ben Gurion University of the Negev Research and Development Autority | Red microalgae expressing exogenous polypeptides and methods of generating and utilizing same |
JP4796786B2 (ja) * | 2005-04-28 | 2011-10-19 | 富士フイルム株式会社 | ラビリンチュラ類を形質転換可能なベクター |
JP4796787B2 (ja) | 2005-04-28 | 2011-10-19 | 富士フイルム株式会社 | ラビリンチュラ類への遺伝子導入法 |
US7951384B2 (en) * | 2005-08-05 | 2011-05-31 | University Of Massachusetts | Virus-like particles as vaccines for paramyxovirus |
US9216212B2 (en) * | 2005-08-05 | 2015-12-22 | University Of Massachusetts | Virus-like particles as vaccines for paramyxovirus |
WO2009076778A1 (en) | 2007-11-27 | 2009-06-25 | Medicago Inc. | Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin |
CA2615372A1 (en) * | 2007-07-13 | 2009-01-13 | Marc-Andre D'aoust | Influenza virus-like particles (vlps) comprising hemagglutinin |
EP2090648A1 (en) * | 2008-02-12 | 2009-08-19 | Institut Francais de Recherche pour l'Exploitation de la Mere(Ifremer) | Production of glycosylated polypeptides in microalgae |
US7794714B2 (en) * | 2008-03-14 | 2010-09-14 | The United States Of America As Represented By The Secretary Of Agriculture | Newcastle disease virus monoclonal antibodies |
US8394384B2 (en) | 2008-11-28 | 2013-03-12 | Merial Limited | Recombinant avian influenza vaccine and uses thereof |
CA3153553A1 (en) * | 2009-12-28 | 2011-07-28 | Sanofi Vaccine Technologies, S.A.S. | Methods of producing heterologous proteins comprising membrane domains in microalgal extracellular bodies |
US9012197B2 (en) * | 2009-12-28 | 2015-04-21 | Merial, Inc. | Production of hemagglutinin-neuraminidase protein in microalgae |
-
2010
- 2010-12-28 MX MX2012007545A patent/MX351643B/es active IP Right Grant
- 2010-12-28 PE PE2012000888A patent/PE20121685A1/es not_active Application Discontinuation
- 2010-12-28 KR KR1020127020029A patent/KR20120101572A/ko not_active Application Discontinuation
- 2010-12-28 AR ARP100104979A patent/AR079767A1/es not_active Application Discontinuation
- 2010-12-28 EP EP10844257.5A patent/EP2519258B1/en active Active
- 2010-12-28 CA CA2785653A patent/CA2785653C/en active Active
- 2010-12-28 JP JP2012546255A patent/JP5933451B2/ja active Active
- 2010-12-28 EP EP17153588.3A patent/EP3213766A1/en not_active Withdrawn
- 2010-12-28 US US12/979,677 patent/US10633667B2/en active Active
- 2010-12-28 CN CN2010800634100A patent/CN103260643A/zh active Pending
- 2010-12-28 WO PCT/US2010/062209 patent/WO2011090708A2/en active Application Filing
-
2012
- 2012-06-27 DO DO2012000187A patent/DOP2012000187A/es unknown
-
2020
- 2020-10-19 AR ARP200102888A patent/AR122325A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
JP2013515747A (ja) | 2013-05-09 |
CA2785653C (en) | 2018-05-01 |
US10633667B2 (en) | 2020-04-28 |
EP2519258B1 (en) | 2017-07-26 |
PE20121685A1 (es) | 2012-12-28 |
US20110162115A1 (en) | 2011-06-30 |
WO2011090708A3 (en) | 2011-12-15 |
EP3213766A1 (en) | 2017-09-06 |
JP5933451B2 (ja) | 2016-06-08 |
DOP2012000187A (es) | 2012-12-15 |
CN103260643A (zh) | 2013-08-21 |
WO2011090708A2 (en) | 2011-07-28 |
MX351643B (es) | 2017-10-23 |
KR20120101572A (ko) | 2012-09-13 |
MX2012007545A (es) | 2012-11-12 |
EP2519258A2 (en) | 2012-11-07 |
AR079767A1 (es) | 2012-02-15 |
CA2785653A1 (en) | 2011-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR122325A2 (es) | Antígeno ndv recombinante y usos del mismo | |
JP2020039347A (ja) | 新規多価ナノ粒子に基づくワクチン | |
ES2612741T3 (es) | Proteínas de fusión proteína n de un virus de la familia paramyxoviridae-proteína de interés | |
ES2330309T3 (es) | Adnc infeccioso de una cepa de vacuna aprobada de virus del sarampion. uso para composiciones inmunogenicas. | |
RU2012143624A (ru) | Рекомбинантные вакцины против вируса " синего языка ", их применение | |
AR089039A1 (es) | Vectores recombinantes de hvt que expresan antigenos de patogenos de aves y sus usos | |
JP2013515747A5 (es) | ||
AR061484A1 (es) | Secuencias de adn vectores proteinas y usos de hemaglutinina de gripe aviar | |
MX347997B (es) | Vacunas aviares vectorizadas con el virus de la enfermedad de newcastle. | |
SI2445928T1 (en) | HYPER PARTICULARS, SIMILAR VIRUSES OF GRIPE, WHICH HAVE EXPOSED HEMAGLUTININE | |
MX2021015465A (es) | Vacuna para fiebre porcina africana. | |
RU2015135890A (ru) | Композиция вакцины | |
RU2011126359A (ru) | Рекомбинантная вакцина от птичьего гриппа и ее применение | |
EP2571990A4 (en) | UNIVERSAL DENGUE VIRUS SEQUENCES AND METHOD FOR THEIR USE | |
RU2018122755A (ru) | Слитые белки fmdv-e2 и их применение | |
Xu et al. | Immunogenicity of T7 bacteriophage nanoparticles displaying GH loop of foot-and-mouth disease virus (FMDV) | |
JP7472019B2 (ja) | 狂犬病ウイルスワクチン | |
WO2014205579A4 (en) | Modified matrix proteins of vesicular stomatitis virus | |
JP2023159327A (ja) | ネコ白血病ウイルスワクチン | |
NZ598605A (en) | Vaccine against african horse sickness virus | |
JP2023024998A5 (es) | ||
RU2012149036A (ru) | Векторы парапоксвируса, содержащие антиген вируса бешенства | |
RU2013102413A (ru) | Парапоксвирусные векторы | |
CN104119442A (zh) | 牛a型口蹄疫多表位疫苗及其制备方法和应用 | |
AR122379A1 (es) | Composiciones inmunogénicas y vacunas de covid-19 vectorizadas con sarampión |